← SynDRA
ITACITINIB
SynDRA canonical compound SYN0038346 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | JAK1 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- JAK1 INHIBITOR
- Tyrosine-protein kinase JAK1 inhibitor
- JAK2 INHIBITOR
- JAK inhibitor
ATC classes
- L04A · IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- INCB-039110
- Incb-39110
- Incb39110
- INCB039110
- Examlpe 294 [WO2011112662]
- INCB 039110
- INCB 39110
- itacitinibum
- RefChem:792463
- INCB39110
- Itacitinib (INCB39110)
- Itacitinib [USAN]
- UNII-19J3781LPM
- C26H23F4N9O
- MFCD28579595
- ITACITINIB [INN]
- Itacitinib (USAN/INN)
- Itacitinib [USAN:INN]
- ITACITINIB [WHO-DD]
- Itacitinib(INCB039110)
- Itacitinib; INCB039110
- Itacitinib(INCB039110)?
- GTPL8364
- orb1303457
- SCHEMBL2396080
- Itacitinib (INCB-039110)
- SCHEMBL29360482
- SCHEMBL29377548
- SCHEMBL29456952
- BDBM246868
- GLXC-10668
- EX-A1674
- JDC29890
- NSC792849
- NSC796224
- NSC801001
- s7812
- AKOS027423693
- AT16231
Look up ITACITINIB in the interactive SynDRA portal →